Who backs Seaport Therapeutics?
13 investors| Investor | Type |
|---|---|
| General Atlantic | Growth equity |
| Goldman Sachs Asset Management | Other |
| ARCH Venture Partners | Venture capital |
| Hawktail | Venture capital |
| T. Rowe Price Group | — |
| CPP Investments | Other |
| The Invus Group | PE / buyout |
| Foresite Capital | Venture capital |
| Third Rock Ventures | Venture capital |
| Gray's Creek Capital Partners | Family office |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Seaport Therapeutics investors
13 investors are on record for Seaport Therapeutics, including General Atlantic, Goldman Sachs Asset Management, ARCH Venture Partners and Hawktail. By type, the record holds 4 venture capital firms and 1 family office. The later-stage round in Oct 2024 drew 33 investors.
Free account
More of Seaport Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Seaport Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Seaport Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View